Portal de Periódicos da CAPES

Menopausal estrogen replacement therapy in women with breast cancer

1995; Wiley; Volume: 75; Issue: 1 Linguagem: Inglês

10.1002/1097-0142(19950101)75

1097-0142

Kathleen I. Pritchard, Carol Sawka,

Cancer Treatment and Pharmacology

CancerVolume 75, Issue 1 p. 1-3 ArticleFree Access Menopausal estrogen replacement therapy in women with breast cancer Kathleen I. Pritchard M.D., Corresponding Author Kathleen I. Pritchard M.D. Department of Medicine, University of Toronto, and the Division of Medical Oncology, Toronto-Sunnybrook Regional Cancer Centre, Ontario Cancer Treatment and Research Foundation, Toronto, Ontario, CanadaToronto-Sunnybrook Regional Cancer Centre, 2075 Bayview Avenue, Toronto, Ontario M4N 3M5, Canada===Search for more papers by this authorCarol A. Sawka M.D., Carol A. Sawka M.D. Department of Medicine, University of Toronto, and the Division of Medical Oncology, Toronto-Sunnybrook Regional Cancer Centre, Ontario Cancer Treatment and Research Foundation, Toronto, Ontario, CanadaSearch for more papers by this author Kathleen I. Pritchard M.D., Corresponding Author Kathleen I. Pritchard M.D. Department of Medicine, University of Toronto, and the Division of Medical Oncology, Toronto-Sunnybrook Regional Cancer Centre, Ontario Cancer Treatment and Research Foundation, Toronto, Ontario, CanadaToronto-Sunnybrook Regional Cancer Centre, 2075 Bayview Avenue, Toronto, Ontario M4N 3M5, Canada===Search for more papers by this authorCarol A. Sawka M.D., Carol A. Sawka M.D. Department of Medicine, University of Toronto, and the Division of Medical Oncology, Toronto-Sunnybrook Regional Cancer Centre, Ontario Cancer Treatment and Research Foundation, Toronto, Ontario, CanadaSearch for more papers by this author First published: 1 January 1995 https://doi.org/10.1002/1097-0142(19950101)75:1 3.0.CO;2-1Citations: 13AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 Notelovitz M. Estrogen replacement therapy: indications, contraindications, and agent selection. Am J Obstet Gynecol 1989; 161: 1832– 41. 2 Coope J. Double-blind cross-over study of estrogen replacement therapy. In S Campbell, ed. Management of the menopause and the post-menopausal years. Lancaster, England: MTP Press Ltd., 1976; 159– 68. 3 Daly E, Gray A, Barlow D, McPherson K, Roche M, Vessey M. Measuring the impact of menopausal symptoms in quality of life. Br Med J 1993; 307: 836– 40. 4 Henderson BE. The cancer question: an overview of recent epidemiologic and retrospective data. Am J Obstet Gynecol 1989; 161: 1859– 64. 5 Voigt LF, Weiss NS, Chu J, Daling DR, McKnight B, van Belle G. Progestagen supplementation of exogenous estrogens and risk of endometrial cancer. Lancet 1991; 338: 274– 7. 6 Sillero-Arenas M, Delgado-Rodriguez M, Rodigues-Canteras R, Bueno-Cavanillas A, Galvez-Vargas R. Menopausal hormone replacement therapy and breast cancer: a meta-analysis. Obstet Gynecol 1992; 79: 286– 94. 7 Colditz GA, Egan KM, Stampfer MJ. Hormone replacement therapy and risk of breast cancer: Results from epidemiologic studies. Am J Obstet Gynecol 1993; 168: 1473– 80. 8 Weiss NS, Ure CL, Ballard JH, Williams AR, Daling JR. Decreased risk of fractures of the hip and lower forearm with post-menopausal use of estrogen. N Engl J Med 1980; 303: 1195– 8. 9 Barrett-Connor E, Bush TL. Estrogen and coronary heart disease in women. JAMA 1991; 265: 1861– 7. 10 Society of Obstetricians and Gynecologists of Canada. Canadian Menopause Consensus Conference. J Soc Obstet Gynecol Canada 1994; 16 (5): 4– 40. 11 Henderson BE, Ross R, Bernstein L. Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res 1988; 48: 246– 53. 12 Rose DP. Endocrine epidemiology of male breast cancer. Anti-cancer Res 1988; 8: 845– 50. 13 Arafah BM, Finegan HM, Roe J. Hormone dependency in N-nitrosomethylurea-induced rat mammary tumors. Endocrinology 1982; 111: 584– 8. 14 Clark RM, Chua T. Breast cancer and pregnancy: the ultimate challenge. Clin Oncol 1989; 1: 11– 8. 15 Goodwin PJ. Decision analysis (DA) of estrogen replacement therapy (ERT) in women made prematurely menopausal during adjuvant chemotherapy (ADJ CXT) for breast cancer (BC) [abstract]. Breast Cancer Res Treat 1989; 14: 147. 16 Cobleigh MA, Berris RF, Bush T, Davidson NE, et al. Estrogen replacement therapy in breast cancer survivors. JAMA 1994; 272: 540– 5. 17 Dhodapkar MV, Ingle JN, Ahmann DL. Estrogen replacement therapy withdrawal and regression of metastatic breast cancer. Cancer 1995; 75: 0000– 00. 18 Gottardes MN, Jordan VC. Development of tamoxifen-stimulated growth of MCF-7 tumors in athymic mice after long-term antiestrogen administration. Cancer Res 1988; 48: 5183– 7. Citing Literature Volume75, Issue11 January 1995Pages 1-3 ReferencesRelatedInformation